| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000016418 |
| Receipt No. | R000019067 |
| Official scientific title of the study | Chemotherapy in Japanese advanced lung cancer patients: a descriptive study using database |
| Date of disclosure of the study information | 2015/02/02 |
| Last modified on | 2018/01/01 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Chemotherapy in Japanese advanced lung cancer patients: a descriptive study using database | |
| Title of the study (Brief title) | Chemotherapy in advanced lung cancer patients: a descriptive study | |
| Region |
|
|
| Condition | |||
| Condition | Advanced lung cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Describe the detail of chemotherapy regimens for advanced lung cancer patients in Japan. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The proportion of each chemotherapy regimen. |
| Key secondary outcomes | Overall survival, costs, adverse events of each chemotherapy regimen. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | -Diagnosed with C34 in International Classification of Diseases, 10th revision (ICD-10) between 2004/1-2014/9
-Stage IIIB or IV |
|||
| Key exclusion criteria | -18>
-Received thoracic radiotherapy within 8 days of 1st chemotherapy -If they had any previously diagnosed cancers -Did not survive at least 30 days past diagnosis |
|||
| Target sample size | 1000 | |||
| Research contact person | |
| Name of lead principal investigator | KATAOKA Yuki |
| Organization | Graduate School of Medicine and Public Health, Kyoto University |
| Division name | Department of Healthcare Epidemiology |
| Address | Yoshida Konoe-cho, Sakyo-ku, Kyoto, JAPAN |
| TEL | 075-753-4645 |
| youkitikk@gmail.com | |
| Public contact | |
| Name of contact person | KATAOKA Yuki |
| Organization | Graduate School of Medicine and Public Health, Kyoto University |
| Division name | Department of Healthcare Epidemiology |
| Address | Yoshida Konoe-cho, Sakyo-ku, Kyoto, JAPAN |
| TEL | 075-753-4645 |
| Homepage URL | |
| youkitikk@gmail.com | |
| Sponsor | |
| Institute | Department of Healthcare Epidemiology, Graduate School of Medicine and Public Health, Kyoto University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Healthcare Epidemiology, Graduate School of Medicine and Public Health, Kyoto University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Data extracted from database are birth date, gender, department, institution, Brinkman index, insurance, postal cord, height, weight, performance status, ICD-10 codes, EGFR mutation status, Alk mutation status, TNM, ADL score, comorbidity, white blood cells, neutrophil, hemoglobin, platelet, bilirubin, AST, ALT, BUN, creatinin, albumin, tested date, date administered chemotherapy, prescription of gefitinib, erlotinib, afatinib, S-1, UFT, crizotinib, alectinib, death date, and last admission date. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019067 |